SCHEMBL2925438

SCHEMBL2925438

CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)C(=N)N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA9 Q16790 2/20 0.50
SPHK2 Q9NRA0 1/20 0.50
SPHK1 Q9NYA1 1/20 0.50
CA2 P00918 1/20 0.50
GRIN2D O15399 4/20 0.47
GRIN3B O60391 4/20 0.47
GRIN1 Q05586 4/20 0.47
GRIN2A Q12879 4/20 0.47
GRIN2B Q13224 4/20 0.47
GRIN2C Q14957 4/20 0.47
GRIN3A Q8TCU5 4/20 0.47
MGLL Q99685 1/20 0.45
DNM1 Q05193 4/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
NOS3 P29474 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1792839 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL9757960 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL1796035 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL1795316 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL1792845 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL1795318 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL1796039 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL4097875 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL8896468 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1
SCHEMBL11327565 1.00 CA12 (0.50) CA12CA1CA9SPHK2SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1661586-B1 Disinfecting substrate BODE CHEMIE GMBH (DE) 2010-08-04 EP claimed
US-4487826-A EXCELLENT SHELF LIFE AND HEAT SENSITIVITY TOPPAN PRINTING CO., LTD. (JP) 1984-12-11 US claimed
US-20060134056-A1 Use of alkylguanidines as cationic emulsifiers GOLDSCHMIDT AG (DE) 2006-06-22 US disclosed
EP-1671615-A2 Use of alkyl guanidines as cationic emulsifiers Goldschmidt GmbH (DE) 2006-06-21 EP disclosed
EP-0730405-A4 AMPHIPHILIC DERIVATIVES OF GUANIDINE MEGABIOS CORP (US) 1997-02-19 EP disclosed
EP-0730405-A1 AMPHIPHILIC DERIVATIVES OF GUANIDINE MEGABIOS CORPORATION (US) 1996-09-11 EP disclosed
WO-1995014381-A1 AMPHIPHILIC DERIVATIVES OF GUANIDINE MEGABIOS CORPORATION (US) 1995-06-01 WO disclosed
EP-0084890-B1 DIAZOTYPE HEAT DEVELOPMENT RECORDING MEDIUM Toppan Printing Co., Ltd. (JP) 1986-05-21 EP disclosed
US-4487826-A EXCELLENT SHELF LIFE AND HEAT SENSITIVITY TOPPAN PRINTING CO., LTD. (JP) 1984-12-11 US disclosed
EP-0084890-A1 Diazotype heat development recording medium Toppan Printing Co., Ltd. (JP) 1983-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060134056-A1 Use of alkylguanidines as cationic emulsifiers HBG2, GPR18, AAAS CA12 3354/4885CA1 4301/4885CA9 2516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.